The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 10, 2012

Filed:

Oct. 29, 2009
Applicants:

Beat A. Imhof, Conches, CH;

Michel Aurrand-lions, Marseilles, FR;

Inventors:

Beat A. Imhof, Conches, CH;

Michel Aurrand-Lions, Marseilles, FR;

Assignee:

Merck Serono S.A., Coinsins, Vaud, CH;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
G01N 33/53 (2006.01); G01N 33/536 (2006.01); G01N 33/543 (2006.01); G01N 33/567 (2006.01); G01N 33/577 (2006.01); C07K 16/28 (2006.01); C12N 5/20 (2006.01);
U.S. Cl.
CPC ...
Abstract

The present invention relates to a method for providing molecules that are capable of inhibiting angiogenesis, comprising the steps of providing a range of molecules; testing whether these molecules can prevent interaction between JAM-B and JAM-C; testing the positive molecules for their ability to block angiogenesis in vivo; and selecting molecules that are positive in the angiogenesis test as angiogenesis inhibiting molecules. The method may further comprise the step of isolating or producing the angiogenesis inhibiting molecules. The invention further relates to the angiogenesis inhibiting molecules thus provided and produced, to their use in the treatment of cancer, to therapeutical compositions comprising them. In a particular embodiment the invention relates to monoclonal antibodies, in particular Mab H33, to soluble JAM-C and JAM-B and to small molecules.


Find Patent Forward Citations

Loading…